LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Hamed Alborzinia(German Cancer Research Center), José Pedro Friedmann Angeli(University of Würzburg), Andrés F. Flórez(Harvard University), Gabriele Büchel(University of Würzburg), Bernhard Michalke(Goethe University Frankfurt), Felix C. E. Vogel(German Cancer Research Center), Nesrine Aroua(German Cancer Research Center), Marcus Conrad(Helmholtz Zentrum München), Martin Eilers(University of Würzburg), Julie Haenlin(German Cancer Research Center), Elisa Espinet(Institut d'Investigació Biomédica de Bellvitge), Enrico Girardi(Austrian Academy of Sciences), Ulrich Schweizer(University of Bonn), Lisa Schlicker(German Cancer Research Center), Svenja Meierjohann(University of Würzburg), Julianna Patricia Varga(European Molecular Biology Organization), Matthias Fischer(University of Cologne), Ancély Ferreira dos Santos(Universidade de São Paulo), Christoph Bartenhagen(University of Cologne), Jasmin Batani(University of Würzburg), Umut Yildiz(German Cancer Research Center), Giulio Superti‐Furga(Austrian Academy of Sciences), Werner Schmitz(University of Würzburg), Thamara Nishida Xavier da Silva(University of Würzburg), Almut Schulze(German Cancer Research Center), Petra Zeisberger(German Cancer Research Center), Andreas Trumpp(German Cancer Research Center), Florêncio Porto Freitas(University of Würzburg), Tasneem Cheytan(German Cancer Research Center), Adriana Przybylla(German Cancer Research Center), Zhiyi Chen, Jashuo Zheng(Helmholtz Zentrum München), Marietta Fabiano(University of Bonn)
Cited by 75
Related Papers
FSP1 is a glutathione-independent ferroptosis suppressor
|Nature|2019|3.2k
Lipid metabolism in cancer
|FEBS Journal|2012|1.3k
Myc’s broad reach
|Genes & Development|2008|922